{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,8]],"date-time":"2026-08-08T12:47:38Z","timestamp":1786193258475,"version":"3.56.0"},"reference-count":52,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007129","name":"Shandong Province Natural Science Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007129","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100013290","name":"National Key Research and Development Program of China Stem Cell and Translational Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100013290","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010029","name":"Taishan Scholar Foundation of Shandong Province","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100010029","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Computer Methods and Programs in Biomedicine"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.cmpb.2026.109534","type":"journal-article","created":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T06:45:21Z","timestamp":1782888321000},"page":"109534","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["SynTME: A tumor microenvironment-aware, pharmacology-inspired multi-stage framework for drug synergy prediction"],"prefix":"10.1016","volume":"285","author":[{"ORCID":"https:\/\/orcid.org\/0009-0006-8512-1515","authenticated-orcid":false,"given":"Song","family":"Gao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peifu","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingyang","family":"Ge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenxu","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guoliang","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zilin","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tao","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Na","family":"Kang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.cmpb.2026.109534_b1","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1158\/2159-8290.CD-21-1059","article-title":"Hallmarks of cancer: new dimensions","volume":"12","author":"Hanahan","year":"2022","journal-title":"Cancer Discov."},{"issue":"7899","key":"10.1016\/j.cmpb.2026.109534_b2","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1038\/s41586-022-04437-2","article-title":"Effective drug combinations in breast, colon and pancreatic cancer cells","volume":"603","author":"Jaaks","year":"2022","journal-title":"Nature"},{"issue":"7467","key":"10.1016\/j.cmpb.2026.109534_b3","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1038\/nature12626","article-title":"Influence of tumour micro-environment heterogeneity on therapeutic response","volume":"501","author":"Junttila","year":"2013","journal-title":"Nature"},{"issue":"24","key":"10.1016\/j.cmpb.2026.109534_b4","doi-asserted-by":"crossref","first-page":"17536","DOI":"10.3390\/ijms242417536","article-title":"Insights into the tumor microenvironment\u2014components, functions and therapeutics","volume":"24","author":"Baghy","year":"2023","journal-title":"Int. J. Mol. Sci."},{"issue":"9","key":"10.1016\/j.cmpb.2026.109534_b5","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.1038\/s12276-020-00500-y","article-title":"Combination of anti-angiogenic therapy and immune checkpoint blockade normalizes vascular-immune crosstalk to potentiate cancer immunity","volume":"52","author":"Lee","year":"2020","journal-title":"Exp. Mol. Med."},{"issue":"1","key":"10.1016\/j.cmpb.2026.109534_b6","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1038\/s41698-022-00272-w","article-title":"Tumor microenvironment heterogeneity an important mediator of prostate cancer progression and therapeutic resistance","volume":"6","author":"Ge","year":"2022","journal-title":"NPJ Precis. Oncol."},{"issue":"7","key":"10.1016\/j.cmpb.2026.109534_b7","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2021-002459","article-title":"Systematic review of combinations of targeted or immunotherapy in advanced solid tumors","volume":"9","author":"Tan","year":"2021","journal-title":"J. Immunother. Cancer"},{"issue":"W1","key":"10.1016\/j.cmpb.2026.109534_b8","doi-asserted-by":"crossref","first-page":"W43","DOI":"10.1093\/nar\/gkz337","article-title":"Drugcomb: an integrative cancer drug combination data portal","volume":"47","author":"Zagidullin","year":"2019","journal-title":"Nucleic Acids Res."},{"issue":"6","key":"10.1016\/j.cmpb.2026.109534_b9","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1158\/1535-7163.MCT-15-0843","article-title":"An unbiased oncology compound screen to identify novel combination strategies","volume":"15","author":"O\u2019Neil","year":"2016","journal-title":"Mol. Cancer Ther."},{"issue":"11","key":"10.1016\/j.cmpb.2026.109534_b10","doi-asserted-by":"crossref","first-page":"2336","DOI":"10.1093\/jamia\/ocab162","article-title":"Graphsynergy: a network-inspired deep learning model for anticancer drug combination prediction","volume":"28","author":"Yang","year":"2021","journal-title":"J. Am. Med. Inform. Assoc."},{"issue":"2","key":"10.1016\/j.cmpb.2026.109534_b11","doi-asserted-by":"crossref","DOI":"10.1093\/bib\/bbab587","article-title":"Prodeepsyn: predicting anticancer synergistic drug combinations by embedding cell lines with protein\u2013protein interaction network","volume":"23","author":"Wang","year":"2022","journal-title":"Brief. Bioinform."},{"issue":"10","key":"10.1016\/j.cmpb.2026.109534_b12","doi-asserted-by":"crossref","DOI":"10.1093\/bioinformatics\/btad607","article-title":"Predicting synergistic anticancer drug combination based on low-rank global attention mechanism and bilinear predictor","volume":"39","author":"Gan","year":"2023","journal-title":"Bioinformatics"},{"issue":"2","key":"10.1016\/j.cmpb.2026.109534_b13","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pcbi.1008653","article-title":"Transynergy: Mechanism-driven interpretable deep neural network for the synergistic prediction and pathway deconvolution of drug combinations","volume":"17","author":"Liu","year":"2021","journal-title":"PLoS Comput. Biol."},{"issue":"5","key":"10.1016\/j.cmpb.2026.109534_b14","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1158\/1541-7786.MCR-21-0735","article-title":"Synpathy: Predicting drug synergy through drug-associated pathways using deep learning","volume":"20","author":"Tang","year":"2022","journal-title":"Mol. Cancer Res."},{"issue":"2","key":"10.1016\/j.cmpb.2026.109534_b15","doi-asserted-by":"crossref","DOI":"10.1093\/bib\/bbaf192","article-title":"Pathsynergy: a deep learning model for predicting drug synergy in liver cancer","volume":"26","author":"Zhang","year":"2025","journal-title":"Brief. Bioinform."},{"issue":"15","key":"10.1016\/j.cmpb.2026.109534_b16","doi-asserted-by":"crossref","first-page":"3692","DOI":"10.3390\/cancers14153692","article-title":"Advanced cellular models for preclinical drug testing: from 2d cultures to organ-on-a-chip technology","volume":"14","author":"Foglizzo","year":"2022","journal-title":"Cancers"},{"issue":"9","key":"10.1016\/j.cmpb.2026.109534_b17","doi-asserted-by":"crossref","first-page":"1538","DOI":"10.1093\/bioinformatics\/btx806","article-title":"Deepsynergy: predicting anti-cancer drug synergy with deep learning","volume":"34","author":"Preuer","year":"2018","journal-title":"Bioinformatics"},{"issue":"1","key":"10.1016\/j.cmpb.2026.109534_b18","doi-asserted-by":"crossref","DOI":"10.1093\/bib\/bbab390","article-title":"Deepdds: deep graph neural network with attention mechanism to predict synergistic drug combinations","volume":"23","author":"Wang","year":"2022","journal-title":"Brief. Bioinform."},{"issue":"4","key":"10.1016\/j.cmpb.2026.109534_b19","doi-asserted-by":"crossref","first-page":"2334","DOI":"10.1109\/TCBB.2021.3086702","article-title":"Matchmaker: a deep learning framework for drug synergy prediction","volume":"19","author":"Kuru","year":"2021","journal-title":"IEEE\/ACM Trans. Comput. Biol. Bioinform."},{"issue":"2","key":"10.1016\/j.cmpb.2026.109534_b20","doi-asserted-by":"crossref","DOI":"10.1093\/bib\/bbae015","article-title":"Synergyx: a multi-modality mutual attention network for interpretable drug synergy prediction","volume":"25","author":"Guo","year":"2024","journal-title":"Brief. Bioinform."},{"issue":"7","key":"10.1016\/j.cmpb.2026.109534_b21","doi-asserted-by":"crossref","first-page":"2854","DOI":"10.1021\/acs.jcim.3c00709","article-title":"Attensyn: an attention-based deep graph neural network for anticancer synergistic drug combination prediction","volume":"64","author":"Wang","year":"2023","journal-title":"J. Chem. Inf. Model."},{"issue":"6","key":"10.1016\/j.cmpb.2026.109534_b22","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1038\/s41422-020-0337-2","article-title":"The future of cancer immunotherapy: microenvironment-targeting combinations","volume":"30","author":"Murciano-Goroff","year":"2020","journal-title":"Cell Res."},{"key":"10.1016\/j.cmpb.2026.109534_b23","series-title":"Stem Cell Transcriptional Networks: Methods and Protocols","first-page":"135","article-title":"Profiling cell type abundance and expression in bulk tissues with cibersortx","author":"Steen","year":"2020"},{"key":"10.1016\/j.cmpb.2026.109534_b24","first-page":"1","article-title":"Film: Visual reasoning with a general conditioning layer","volume":"Vol. 32","author":"Perez","year":"2018"},{"issue":"D1","key":"10.1016\/j.cmpb.2026.109534_b25","first-page":"D871","article-title":"Drugcombdb: a comprehensive database of drug combinations toward the discovery of combinatorial therapy","volume":"48","author":"Liu","year":"2020","journal-title":"Nucleic Acids Res."},{"issue":"4","key":"10.1016\/j.cmpb.2026.109534_b26","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1016\/j.immuni.2018.03.023","article-title":"The immune landscape of cancer","volume":"48","author":"Malta","year":"2018","journal-title":"Immunity"},{"key":"10.1016\/j.cmpb.2026.109534_b27","series-title":"The ucsc xena platform for public and private cancer genomics data visualization and interpretation","first-page":"326470","author":"Goldman","year":"2018"},{"issue":"31.10","key":"10.1016\/j.cmpb.2026.109534_b28","first-page":"5281","article-title":"Rdkit: A software suite for cheminformatics, computational chemistry, and predictive modeling","volume":"8","author":"Landrum","year":"2013","journal-title":"Greg Landrum"},{"issue":"D1","key":"10.1016\/j.cmpb.2026.109534_b29","doi-asserted-by":"crossref","first-page":"D1100","DOI":"10.1093\/nar\/gkr777","article-title":"Chembl: a large-scale bioactivity database for drug discovery","volume":"40","author":"Gaulton","year":"2012","journal-title":"Nucleic Acids Res."},{"issue":"2","key":"10.1016\/j.cmpb.2026.109534_b30","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1021\/jm900817u","article-title":"Three-dimensional pharmacophore methods in drug discovery","volume":"53","author":"Leach","year":"2010","journal-title":"J. Med. Chem."},{"issue":"11","key":"10.1016\/j.cmpb.2026.109534_b31","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1002\/emmm.201100176","article-title":"Oncogene addiction as a foundational rationale for targeted anti-cancer therapy: promises and perils","volume":"3","author":"Torti","year":"2011","journal-title":"EMBO Mol. Med."},{"issue":"3","key":"10.1016\/j.cmpb.2026.109534_b32","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1016\/j.cell.2017.06.010","article-title":"Defining a cancer dependency map","volume":"170","author":"Tsherniak","year":"2017","journal-title":"Cell"},{"issue":"11","key":"10.1016\/j.cmpb.2026.109534_b33","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1038\/nchembio.232","article-title":"The role of dynamic conformational ensembles in biomolecular recognition","volume":"5","author":"Boehr","year":"2009","journal-title":"Nat. Chem. Biol."},{"key":"10.1016\/j.cmpb.2026.109534_b34","doi-asserted-by":"crossref","first-page":"7893","DOI":"10.2147\/CMAR.S127848","article-title":"Evaluating vandetanib in the treatment of medullary thyroid cancer: patient-reported outcomes","author":"Fallahi","year":"2019","journal-title":"Cancer Manag. Res."},{"issue":"19","key":"10.1016\/j.cmpb.2026.109534_b35","doi-asserted-by":"crossref","first-page":"10549","DOI":"10.1021\/acs.jcim.5c01310","article-title":"Dgss: a dynamic interaction graph neural network with specific substructure awareness for drug synergy prediction","volume":"65","author":"Ge","year":"2025","journal-title":"J. Chem. Inf. Model."},{"key":"10.1016\/j.cmpb.2026.109534_b36","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2023.115626","article-title":"Quinazoline-based vegfr-2 inhibitors as potential anti-angiogenic agents: A contemporary perspective of sar and molecular docking studies","volume":"259","author":"Moradi","year":"2023","journal-title":"Eur. J. Med. Chem."},{"issue":"11","key":"10.1016\/j.cmpb.2026.109534_b37","doi-asserted-by":"crossref","first-page":"3480","DOI":"10.3390\/ijms19113480","article-title":"Anthracyclines as topoisomerase ii poisons: from early studies to new perspectives","volume":"19","author":"Marinello","year":"2018","journal-title":"Int. J. Mol. Sci."},{"issue":"2","key":"10.1016\/j.cmpb.2026.109534_b38","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.canlet.2007.08.019","article-title":"Inhibition of stat3 increases doxorubicin sensitivity in a human metastatic breast cancer cell line","volume":"258","author":"Gariboldi","year":"2007","journal-title":"Cancer Lett."},{"issue":"1","key":"10.1016\/j.cmpb.2026.109534_b39","doi-asserted-by":"crossref","first-page":"29382","DOI":"10.1038\/srep29382","article-title":"Linifanib (abt-869) potentiates the efficacy of chemotherapeutic agents through the suppression of receptor tyrosine kinase-mediated akt\/mtor signaling pathways in gastric cancer","volume":"6","author":"Chen","year":"2016","journal-title":"Sci. Rep."},{"issue":"5","key":"10.1016\/j.cmpb.2026.109534_b40","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1016\/S0026-895X(25)09073-X","article-title":"Cell cycle-dependent cytotoxicity, g2\/m phase arrest, and disruption of p34cdc2\/cyclin b1 activity induced by doxorubicin in synchronized p388 cells","volume":"49","author":"Ling","year":"1996","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.cmpb.2026.109534_b41","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2020.564601","article-title":"Parp inhibitors: clinical relevance, mechanisms of action and tumor resistance","volume":"8","author":"Rose","year":"2020","journal-title":"Front. Cell Dev. Biol."},{"issue":"2","key":"10.1016\/j.cmpb.2026.109534_b42","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1158\/0008-5472.CAN-12-2325","article-title":"Vegfa-vegfr pathway blockade inhibits tumor-induced regulatory t-cell proliferation in colorectal cancer","volume":"73","author":"Terme","year":"2013","journal-title":"Cancer Res."},{"issue":"9","key":"10.1016\/j.cmpb.2026.109534_b43","doi-asserted-by":"crossref","first-page":"1743","DOI":"10.1016\/j.jid.2020.01.015","article-title":"Flotillin and ap2a1\/2 promote insulin-like growth factor receptor-1 association with clathrin and internalization in primary human keratinocytes","volume":"140","author":"Dam","year":"2020","journal-title":"J. Investig. Dermatol."},{"issue":"1","key":"10.1016\/j.cmpb.2026.109534_b44","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0029870","article-title":"Herc6 is the main e3 ligase for global isg15 conjugation in mouse cells","volume":"7","author":"Oudshoorn","year":"2012","journal-title":"PLoS One"},{"issue":"6","key":"10.1016\/j.cmpb.2026.109534_b45","doi-asserted-by":"crossref","first-page":"2234","DOI":"10.1093\/nar\/gkq1117","article-title":"Pak1ip1, a ribosomal stress-induced nucleolar protein, regulates cell proliferation via the p53\u2013mdm2 loop","volume":"39","author":"Yu","year":"2011","journal-title":"Nucleic Acids Res."},{"issue":"1","key":"10.1016\/j.cmpb.2026.109534_b46","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1038\/s41392-025-02242-7","article-title":"Therapeutic potential of tumor-associated neutrophils: dual role and phenotypic plasticity","volume":"10","author":"Zhou","year":"2025","journal-title":"Signal Transduct. Target. Ther."},{"issue":"10","key":"10.1016\/j.cmpb.2026.109534_b47","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1038\/ni.2703","article-title":"Innate and adaptive immune cells in the tumor microenvironment","volume":"14","author":"Gajewski","year":"2013","journal-title":"Nature Immunol."},{"key":"10.1016\/j.cmpb.2026.109534_b48","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.csbj.2018.11.004","article-title":"Fates of cd8+ t cells in tumor microenvironment","volume":"17","author":"Maimela","year":"2019","journal-title":"Comput. Struct. Biotechnol. J."},{"issue":"9","key":"10.1016\/j.cmpb.2026.109534_b49","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1158\/2159-8290.CD-15-0563","article-title":"Adaptive immune resistance: how cancer protects from immune attack","volume":"5","author":"Ribas","year":"2015","journal-title":"Cancer Discov."},{"issue":"12","key":"10.1016\/j.cmpb.2026.109534_b50","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1016\/j.annonc.2023.10.124","article-title":"The impact of genomic context on outcomes of solid cancer patients treated with genotype-matched targeted therapies: a comprehensive review","volume":"34","author":"Fulton-Ward","year":"2023","journal-title":"Ann. Oncol."},{"issue":"8","key":"10.1016\/j.cmpb.2026.109534_b51","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.1093\/annonc\/mdy196","article-title":"Predictive biomarkers for response to egfr-directed monoclonal antibodies for advanced squamous cell lung cancer","volume":"29","author":"Bonomi","year":"2018","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.cmpb.2026.109534_b52","doi-asserted-by":"crossref","DOI":"10.1016\/j.ctrv.2020.102064","article-title":"Biomarkers for her2-positive metastatic breast cancer: Beyond hormone receptors","volume":"88","author":"Dieci","year":"2020","journal-title":"Cancer Treat. Rev."}],"container-title":["Computer Methods and Programs in Biomedicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S016926072600283X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S016926072600283X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,8]],"date-time":"2026-08-08T12:30:25Z","timestamp":1786192225000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S016926072600283X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":52,"alternative-id":["S016926072600283X"],"URL":"https:\/\/doi.org\/10.1016\/j.cmpb.2026.109534","relation":{},"ISSN":["0169-2607"],"issn-type":[{"value":"0169-2607","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"SynTME: A tumor microenvironment-aware, pharmacology-inspired multi-stage framework for drug synergy prediction","name":"articletitle","label":"Article Title"},{"value":"Computer Methods and Programs in Biomedicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cmpb.2026.109534","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"109534"}}